Literature DB >> 20705840

AIDS/HIV. A boost for HIV vaccine design.

Dennis R Burton1, Robin A Weiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20705840     DOI： 10.1126/science.1194693

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  40 in total

1.  Understanding the molecular mechanism of the broad and potent neutralization of HIV-1 by antibody VRC01 from the perspective of molecular dynamics simulation and binding free energy calculations.

Authors:  Yan Zhang; Dabo Pan; Yulin Shen; Nengzhi Jin; Huanxiang Liu; Xiaojun Yao
Journal:  J Mol Model       Date:  2012-05-29       Impact factor: 1.810

2.  Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab.

Authors:  Kar Muthumani; Seleeke Flingai; Megan Wise; Colleen Tingey; Kenneth E Ugen; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2013-09-17       Impact factor: 3.452

3.  Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.

Authors:  Dennis R Burton; Ann J Hessell; Brandon F Keele; Per Johan Klasse; Thomas A Ketas; Brian Moldt; D Cameron Dunlop; Pascal Poignard; Lara A Doyle; Lisa Cavacini; Ronald S Veazey; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

4.  Almighty antibodies? A new wave of antibody-based approaches aims to combat HIV.

Authors:  Erika Check Hayden
Journal:  Nat Med       Date:  2015-07       Impact factor: 53.440

5.  Immunisation with foamy virus Bet fusion proteins as novel strategy for HIV-1 epitope delivery.

Authors:  Michael Mühle; Kerstin Hoffmann; Martin Löchelt; Joachim Denner
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

6.  Liposomes for HIV prophylaxis.

Authors:  Nikita K Malavia; David Zurakowski; Avi Schroeder; Amy M Princiotto; Anna R Laury; Hila E Barash; Joseph Sodroski; Robert Langer; Navid Madani; Daniel S Kohane
Journal:  Biomaterials       Date:  2011-09-08       Impact factor: 12.479

7.  Two closely related Env antigens from the same patient elicited different spectra of neutralizing antibodies against heterologous HIV-1 isolates.

Authors:  Michael Vaine; Maria Duenas-Decamp; Paul Peters; Qin Liu; James Arthos; Shixia Wang; Paul Clapham; Shan Lu
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

8.  Functional characterization of the recombinant HIV-neutralizing monoclonal antibody 2F5 produced in maize seeds.

Authors:  M Sabalza; L Madeira; C van Dolleweerd; J K Ma; T Capell; P Christou
Journal:  Plant Mol Biol       Date:  2012-09-11       Impact factor: 4.076

9.  Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1.

Authors:  Craig S Pace; Ruijiang Song; Christina Ochsenbauer; Chasity D Andrews; David Franco; Jian Yu; Deena A Oren; Michael S Seaman; David D Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

10.  Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein.

Authors:  Hannes Uchtenhagen; Torben Schiffner; Emma Bowles; Leo Heyndrickx; Celia LaBranche; Steven E Applequist; Marianne Jansson; Thushan De Silva; Jaap Willem Back; Adnane Achour; Gabriella Scarlatti; Anders Fomsgaard; David Montefiori; Guillaume Stewart-Jones; Anna-Lena Spetz
Journal:  J Immunol       Date:  2014-05-14       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.